← Back to Search

Electrical Stimulation

Active Group A for Urge Incontinence

N/A
Recruiting
Research Sponsored by Elidah, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This study is evaluating whether a new electrical muscle stimulation device may help reduce urge incontinence.

Eligible Conditions
  • Urge Incontinence

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy assessed by average number of urinary incontinence episodes per day
Safety assessed by number of serious adverse events
Secondary outcome measures
Efficacy assessed by change in Incontinence quality of life questionnaire (I-QOL)
Efficacy assessed by reduction in average Pads used per day
Efficacy assessed by reduction in average bathroom visits
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active Group AExperimental Treatment1 Intervention
Electrical muscle stimulator and surface applied electrode shaped to fit the perineal region, with stimulation group A.
Group II: Active Group BActive Control1 Intervention
Electrical muscle stimulator and surface applied electrode shaped to fit the perineal region with stimulation group B.

Find a Location

Who is running the clinical trial?

Elidah, Inc.Lead Sponsor
1 Previous Clinical Trials
12 Total Patients Enrolled
Gloria Kolb, M.S.Study DirectorElidah, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025